The funded federally.

AHF led sustained advocacy marketing campaign leads to BMS’s present of discounts in AIDS drug pricing Following ongoing advocacy promotions spearheaded by AIDS Health care Foundation that targeted many of the largest AIDS medication companies over their prices and rebate policies intended for the country’s AIDS Drug Assistance Programs , the funded federally, state run programs supplying lifesaving AIDS medications to low-income Americans in require, that the last remaining major AIDS medication company, Bristol-Myers Squibb today announced an contract that will provide additional expense savings to cash-strapped ADAPs nationwide. The contract, with the ADAP Crisis Job Push of the National Alliance of Condition & Territorial Helps Directors , today was announced in a news release., Viiv Healthcare and Abbott Labs all provided significant discounts and prices concessions to cash-strapped ADAPs .

The proposed spending budget comes after shortly, and is straight at odds with, the President’s December 2011 announced goals of putting 2 million more folks on treatment by the end of 2013, and of fabricating an AIDS free generation. This latest action simply confirms what folks with HIV/AIDS and their advocates have long suspected – the President just is not committed to fighting global AIDS. Arriving on the heels of the President’s flowery rhetoric last December, the cynicism is merely breathtaking, stated Michael Weinstein, President of AIDS Healthcare Foundation, which provides free HIV/AIDS medical care to over 125,000 people in 26 countries abroad.